A major international study has found that semaglutide, a drug already used to treat type 2 diabetes and obesity, can ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.

"It provides patients with additional choices when we think about treating fatty liver disease." MASH is a severe form of metabolic dysfunction-associated steatotic liver disease (MASLD), which ...

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...

How a commonly “silent disease” is driving urgency and novelty in the liver disease treatment paradigm and what can we hope ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

The reserarchers found that a weekly dose of semaglutide was effective at treating Metabolic Dysfunction-Associated ...

A new study published in the New England Journal of Medicine reveals that medications widely used for diabetes and obesity ...